Michelle Renee Griffin Chinook Therapeutics, Inc. (KDNY) insider trading activity

Michelle Renee Griffin is Director of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 3,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

MICHELLE RENEE GRIFFIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 11 2023	SELL Sale (or disposition) back to the issuer	-	3,300 Reduced 100.0%	0 Common Stock
May 26 2023	BUY Exercise of conversion of derivative security	-	3,300 Added 50.0%	3,300 Common Stock

Also insider at

ADPT

Adaptive Biotechnologies Corp Healthcare

Director

ACER

Acer Therapeutics Inc. Healthcare

Director

HTGM

HTG MOLECULAR DIAGNOSTICS, INC Healthcare

Director

MRG